An comparison of acute toxicities and <scp>patient‐reported</scp> outcomes between intensity‐modulated proton therapy and volumetric‐modulated arc therapy after ipsilateral radiation for head and neck cancers

Abstract

IMPT is associated with decreased dose to OARs and less patient-reported acute deterioration in multiple head and neck domains. A strong consideration for IMPT in ipsilateral head and neck patients with cancer is warranted.